# Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes

> **NCT03655535** · PHASE2 · COMPLETED · sponsor: **Boston Therapeutics** · enrollment: 66 (actual)

## Conditions studied

- Type2 Diabetes Mellitus

## Interventions

- **DRUG:** BTI320
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03655535
- **Lead sponsor:** Boston Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-19
- **Primary completion:** 2019-08-30
- **Final completion:** 2019-08-30
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2020-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03655535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03655535, "Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03655535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*